CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads - Yang - 2021 - Journal of Cellular and Molecular Medicine - Wiley Online Library
Part:BBa K4040015 - parts.igem.org
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
Enrichment and expansion of anti‐CD19 CAR‐T cells with aAPCs or beads.... | Download Scientific Diagram
The QCM frequency shifts of the main steps for the CD19 immobilization... | Download Scientific Diagram
FITC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture
CD19 Positive Cell Isolation Kit
Beads for Research | ProMab
Human CD19 Magnetic Beads MS005 | Proteintech
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy Methods & Clinical Development
Human CD19 Separation Beads | Biocompare.com Kit/Reagent Review
Dynabeads™ CD19 Pan B
Simplified process for the production of anti–CD19-CAR–engineered T cells - Cytotherapy
Anti-Human CD19 Magnetic Particles - DM
Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models | Science Translational Medicine
A novel and efficient tandem CD19- and CD22-directed CAR for B cell ALL: Molecular Therapy
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Anti-CD28 stimulation of CD19-chimeric antigen receptors (CAR) T... | Download Scientific Diagram
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications - Cytotherapy
Anti-Human CD19 Magnetic Particles - DM
